Drug Shortage Report for DIAZEPAM INJECTION USP
Report ID | 115413 |
Drug Identification Number | 02385392 |
Brand name | DIAZEPAM INJECTION USP |
Common or Proper name | DIAZEPAM INJECTION USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | DIAZEPAM |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 2 mL |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-05-20 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-05-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-05-21 | English | Compare |
v4 | 2020-05-20 | French | Compare |
v3 | 2020-05-20 | English | Compare |
v2 | 2020-05-20 | English | Compare |
v1 | 2020-05-20 | English | Compare |
Showing 1 to 5 of 5